CRP and stroke disorder: Based on our expanding knowledge in cardiovascular inflammation and the use of immunomodulatory agents [23], the identification of patients with high inflammatory and atherosclerotic burden could generate the hypothesis that biomarkers such as CRP, could potentially guide the use of immunomodulatory agents, to prevent post-stroke cardiac complications.